Minsheng Securities released a research report on April 27 stating that it gave Doctor Glasses (300622.SZ) a recommended rating. The main reasons for the rating include: 1) incident: Dr. Glasses released its 2024 quarterly report; 2) the year-on-year decline in the local lifestyle service business affected the company's revenue growth rate, expecting steady sales growth due to further business adjustments; 3) Continued refinement of the franchise model to enable the expansion of the sinking market. By the end of 24Q1, the Concrete Glasses Alliance platform had a total of 598 franchise store users who completed the franchise signing process; 4) The gross margin was relatively stable, and a slight increase in sales expenses affected profitability. (Mainichi Keizai Shimbun)
民生证券4月27日发布研报称，给予博士眼镜（300622.SZ）推荐评级。评级理由主要包括：1）事件：博士眼镜发布2024年一季报；2）本地生活服务业务高基数下同比下降影响公司营收增速，期待后续业务进一步调整带来的销售稳健增长；3）持续打磨加盟模式，赋能拓展下沉市场，截至24Q1末砼眼镜联盟平台完成加盟签约流程的加盟门店用户共计598家；4）毛利率较为稳健，销售费用率小幅上升影响盈利能力。（每日经济新闻）
Minsheng Securities released a research report on April 27 stating that it gave Doctor Glasses (300622.SZ) a recommended rating. The main reasons for the rating include: 1) incident: Dr. Glasses released its 2024 quarterly report; 2) the year-on-year decl
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.